☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Neovascular Age-related Macular Degeneration
Innovent Presented Results of IBI302 in P-Ib Clinical Trial for the Treatment of Neovascular Age-Related Macular Degeneration at A...
November 15, 2021
Roche Reports the US FDA's Acceptance of BLA for Faricimab to Treat Diabetic Macular Edema and Neovascular Age-Related Macular Deg...
July 29, 2021
Sandoz Initiates Patient Enrolment of Proposed Biosimilar Aflibercept in P-III MYLIGHT Study for Neovascular Age-Related Macular D...
May 4, 2021
Innovent Reports First Patient Dosing in P-II Trial of IBI302 for Neovascular Age-Related Macular Degeneration
April 30, 2021
Samsung Bioepis Presents Results of SB11 Proposed Biosimilar to Lucentis in P-III Study at the AAO 2020 Virtual
November 11, 2020
Genentech Reports Results of Port Delivery System with Ranibizumab in P-III Archway Study for Neovascular Age-Related Macular Dege...
July 23, 2020
Load more...
Back to Home